Serotonin regulates hepcidin expression via a gut-liver axis

Archive ouverte

Coman, T. | Falabrègue, M. | Rossignol, J. | Bonneau, P. | Djebar, M. | Bigorgne, A. | Mathieu, J | Foretz, Marc | Puy, H. | Peoc’h, K. | Logeart, D. | Cohen-Solal, A. | Launay, J.-M. | Maroteaux, L. | Peyssonnaux, C. | Hermine, O. | Côté, F.

Edité par CCSD -

Abstract Liver hepcidin, is well recognized as the central hormone of systemic iron regulation. Although serotonin is most recognized as a brain neurotransmitter, prodigious quantities are synthesized in gut enterochromaffin cells and several lines of evidence, also identified the gut as an essential sensor and regulator of iron homeostasis. Using a mouse model deficient for peripheral serotonin (Tph1 KO), we identified gut-derived serotonin as a key physiological factor in hepcidin regulation. Serotonin represses hepcidin’s through a 5HT2B receptor-dependent pathway, independently of any other known hepcidin regulators, including bone marrow signals. This regulation is conserved in humans and shows physiological significance as a negative correlation between serotonin and hepcidin levels was observed in a cohort of healthy individuals. Moreover, in pathological situation such as acute heart failure, where iron deficiency has a negative prognostic impact, we provide evidence that an increase in serotonin level seems necessary to repress hepcidin level, to increase iron availability.

Suggestions

Du même auteur

Pre-transplant donor CD4− invariant NKT cell expansion capacity predicts the occurrence of acute graft-versus-host disease

Archive ouverte | Rubio, Marie-Thérèse | CCSD

International audience. Clinically useful pre-transplant predictive factors of acute graft-versus-host-disease (aGVHD) after allogeneic hematopoietic stem cell transplantation (allo-SCT) are lacking. We prospectivel...

Gene Therapy in Patients with Transfusion-Dependent beta-Thalassemia

Archive ouverte | Thompson, A. A. | CCSD

International audience. BACKGROUND Donor availability and transplantation-related risks limit the broad use of allogeneic hematopoietic-cell transplantation in patients with transfusion-dependent beta-thalassemia. A...

Efficacy of anti‐PD1 therapy in relapsed or refractory NK/T cell lymphoma: a matched cohort analysis from the LYSA

Archive ouverte | Marouf, A. | CCSD

International audience

Chargement des enrichissements...